List of Altimmune, Inc. patents

List of Altimmune, Inc. patents

List of Dentsu patents

List of pSemi patents

List of Diversey, Inc. patents

List of snacks patents

List of companies in Quiet Capital's investment portfolio

Patents where

Current Assignee

Name

is

Altimmune, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11541028 Peptide pharmaceuticals for treatment of NASH and other disorders	Patent 11541028 was granted and assigned to Altimmune, Inc. on January, 2023 by the United States Patent and Trademark Office.		Altimmune, Inc.		United States Patent and Trademark Office	11541028	January 3, 2023
	‌ US Patent 11382968 Coronavirus immunogenic compositions and uses thereof	Patent 11382968 was granted and assigned to Altimmune, Inc. on July, 2022 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	11382968	July 12, 2022
	‌ US Patent 9968667 Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax	Patent 9968667 was granted and assigned to Altimmune, Inc. on May, 2018 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	9968667	May 15, 2018
	‌ US Patent 11040099 Rapid and prolonged immunologic therapeutic	Patent 11040099 was granted and assigned to Altimmune, Inc. on June, 2021 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	11040099	June 22, 2021
	‌ US Patent 11040100 Rapid and prolonged immunogic therapeutic	Patent 11040100 was granted and assigned to Altimmune, Inc. on June, 2021 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	11040100	June 22, 2021
	‌ US Patent 9605275 Rapid and prolonged immunologic-therapeutic	Patent 9605275 was granted and assigned to Altimmune, Inc. on March, 2017 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	9605275	March 28, 2017
	‌ US Patent 9175310 Rapid and prolonged immunologic-therapeutic	Patent 9175310 was granted and assigned to Altimmune, Inc. on November, 2015 by the United States Patent and Trademark Office.		Altimmune, Inc.		United States Patent and Trademark Office	9175310	November 3, 2015
	‌ US Patent 11141477 Rapid and prolonged immunologic-therapeutic	Patent 11141477 was granted and assigned to Altimmune, Inc. on October, 2021 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	11141477	October 12, 2021
	‌ US Patent 10183069 Rapid and prolonged immunologic-therapeutic	Patent 10183069 was granted and assigned to Altimmune, Inc. on January, 2019 by the United States Patent and Trademark Office.	Altimmune, Inc.	Altimmune, Inc.		United States Patent and Trademark Office	10183069	January 22, 2019

9 results

0 selected

9 results

0 selected